Parkman Healthcare Partners’s CVS Health CVS Stock Holding History

Parkman Healthcare Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$27.8M	Sell	387,306 -62,906	-14%	-$4.85M	2.87%	9
2025 Q4	$35.7M	Buy	450,212 +70,726	+19%	+$5.58M	3.4%	5
2025 Q3	$28.6M	Sell	379,486 -138,321	-27%	-$9.48M	2.98%	5
2025 Q2	$35.7M	Buy	517,807 +21,071	+4%	+$1.38M	4.11%	1
2025 Q1	$33.7M	Buy	496,736 +316,736	+176%	+$19M	3.99%	2
2024 Q4	$8.08M	Buy	+180,000	New	+$10.1M	1.08%	35
2022 Q4	–	Sell	-117,634	Closed	-$11.2M	–	86
2022 Q3	$11.2M	Buy	117,634 +64,087	+120%	+$6.34M	3.19%	7
2022 Q2	$4.96M	Sell	53,547 -32,071	-37%	-$3.13M	1.83%	18
2022 Q1	$8.66M	Sell	85,618 -47,716	-36%	-$5.01M	2.54%	14
2021 Q4	$13.8M	Buy	+133,334	New	+$12.3M	3.04%	8

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Parkman Healthcare Partners's CVS Position: Q1 2026 in Review

Parkman Healthcare Partners reduced its CVS Health (CVS) stake by 14% in Q1 2026, selling an estimated $4.85M and leaving 387,306 shares worth $27.8M. The position accounts for 2.87% of the portfolio, ranked #9.

Parkman Healthcare Partners first reported a position in CVS in Q4 2021 and has held it in 10 quarters since. The position peaked at $35.7M in Q4 2025. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Parkman Healthcare Partners held 387,306 shares of CVS Health worth $27.8M as of Q1 2026.
Parkman Healthcare Partners sold 62,906 CVS Health shares in Q1 2026, an estimated $4.85M.
CVS Health made up 2.87% of Parkman Healthcare Partners's portfolio in Q1 2026, its #9 holding.
Parkman Healthcare Partners first reported a position in CVS Health in Q4 2021 and has held it in 10 quarters since.
Parkman Healthcare Partners's CVS Health position peaked at $35.7M in Q4 2025.
1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.